FDA Inspection 638764 — Surgi-Care, Inc.

Surgi-Care, Inc. — FEI 3003435341

The FDA completed an inspection of Surgi-Care, Inc. on January 14, 2009 in Waltham, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 14, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Waltham, MA (United States)

Citations

IDCFRDescription
1231121 CFR 1271.160(b)(1)Ensuring appropriate core requirements followed
1232221 CFR 1271.160(b)(4)Training of personnel
1232321 CFR 1271.160(b)(5)Monitoring systems
1243121 CFR 1271.265(e)Procedures and release criteria
1243621 CFR 1271.270(a)Accurate, indelible, legible